Drug Profile
PC 111
Alternative Names: PC-111Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator PinCell
- Class Antibodies
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Pemphigus
Highest Development Phases
- No development reported Pemphigus
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for preclinical development in Pemphigus in Italy
- 15 Aug 2016 PC 111 is available for licensing as of 15 Aug 2016. https://sites.google.com/site/pincellsite/
- 15 Aug 2016 Preclinical trials in Pemphigus in Italy (unspecified route)